Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.

Cahill KS, Chi JH, Day A, Claus EB.

JAMA. 2009 Jul 1;302(1):58-66. doi: 10.1001/jama.2009.956.

PMID:
19567440
2.

Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.

Singh K, Nandyala SV, Marquez-Lara A, Fineberg SJ.

Spine (Phila Pa 1976). 2014 Mar 15;39(6):491-6. doi: 10.1097/BRS.0000000000000167.

PMID:
24365905
3.
4.

Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.

Fineberg SJ, Ahmadinia K, Oglesby M, Patel AA, Singh K.

Spine (Phila Pa 1976). 2013 Jul 1;38(15):1304-9. doi: 10.1097/BRS.0b013e31828f494c.

PMID:
23462577
5.

Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges.

Deyo RA, Ching A, Matsen L, Martin BI, Kreuter W, Jarvik JG, Angier H, Mirza SK.

Spine (Phila Pa 1976). 2012 Feb 1;37(3):222-30. doi: 10.1097/BRS.0b013e31821bfa3a.

6.

Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

Goode AP, Richardson WJ, Schectman RM, Carey TS.

Spine J. 2014 Sep 1;14(9):2051-9. doi: 10.1016/j.spinee.2013.11.042. Epub 2013 Dec 7.

7.

The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database.

Veeravagu A, Cole TS, Jiang B, Ratliff JK, Gidwani RA.

Spine J. 2014 Dec 1;14(12):2929-37. doi: 10.1016/j.spinee.2014.05.010. Epub 2014 May 16.

PMID:
24842396
8.

Morbid obesity increases cost and complication rates in spinal arthrodesis.

Kalanithi PA, Arrigo R, Boakye M.

Spine (Phila Pa 1976). 2012 May 15;37(11):982-8. doi: 10.1097/BRS.0b013e31823bbeef.

PMID:
22037526
9.

Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.

Williams BJ, Smith JS, Fu KM, Hamilton DK, Polly DW Jr, Ames CP, Berven SH, Perra JH, Knapp DR Jr, McCarthy RE, Shaffrey CI; Scoliosis Research Society Morbidity and Mortality Committee.

Spine (Phila Pa 1976). 2011 Sep 15;36(20):1685-91. doi: 10.1097/BRS.0b013e318216d825.

PMID:
21897187
10.

Does bone morphogenetic protein change the operative nonunion rates in spine fusions?

Guppy KH, Paxton EW, Harris J, Alvarez J, Bernbeck J.

Spine (Phila Pa 1976). 2014 Oct 15;39(22):1831-9. doi: 10.1097/BRS.0000000000000534.

PMID:
25299166
11.

Incidence and risk factors for dysphagia after anterior cervical fusion.

Singh K, Marquez-Lara A, Nandyala SV, Patel AA, Fineberg SJ.

Spine (Phila Pa 1976). 2013 Oct 1;38(21):1820-5. doi: 10.1097/BRS.0b013e3182a3dbda.

PMID:
23873236
12.

Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011.

Marquez-Lara A, Nandyala SV, Fineberg SJ, Singh K.

Spine (Phila Pa 1976). 2014 Mar 15;39(6):476-81. doi: 10.1097/BRS.0000000000000165.

PMID:
24365907
13.

Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

Martin BI, Lurie JD, Tosteson AN, Deyo RA, Farrokhi FR, Mirza SK.

Spine J. 2015 Apr 1;15(4):692-9. doi: 10.1016/j.spinee.2014.12.010. Epub 2014 Dec 15.

14.

Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.

Rumalla K, Yarbrough CK, Pugely AJ, Koester L, Dorward IG.

J Neurosurg Spine. 2016 Oct;25(4):500-508. Epub 2016 May 20.

PMID:
27203810
15.

Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins.

Yaremchuk KL, Toma MS, Somers ML, Peterson E.

Laryngoscope. 2010 Oct;120(10):1954-7. doi: 10.1002/lary.21096.

PMID:
20824786
16.

Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.

Hofstetter CP, Hofer AS, Levi AD.

J Neurosurg Spine. 2016 Mar;24(3):457-75. doi: 10.3171/2015.4.SPINE141086. Epub 2015 Nov 27.

PMID:
26613283
17.

Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature.

Singh K, Ahmadinia K, Park DK, Nandyala SV, Marquez-Lara A, Patel AA, Fineberg SJ.

Spine (Phila Pa 1976). 2014 Jan 1;39(1):91-101. doi: 10.1097/BRS.0000000000000004. Review.

PMID:
24026158
18.

Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.

Lam SK, Sayama C, Harris DA, BriceƱo V, Luerssen TG, Jea A.

J Neurosurg Pediatr. 2014 Nov;14(5):476-85. doi: 10.3171/2014.7.PEDS1499. Epub 2014 Aug 29.

PMID:
25171721
19.

Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.

Cole T, Veeravagu A, Jiang B, Ratliff JK.

J Bone Joint Surg Am. 2014 Sep 3;96(17):1409-16. doi: 10.2106/JBJS.M.01016.

PMID:
25187578
20.

Venous thromboembolism after thoracic/thoracolumbar spinal fusion.

Gephart MG, Zygourakis CC, Arrigo RT, Kalanithi PS, Lad SP, Boakye M.

World Neurosurg. 2012 Nov;78(5):545-52. doi: 10.1016/j.wneu.2011.12.089. Epub 2011 Dec 28.

PMID:
22381270

Supplemental Content

Support Center